Cited by 273Cardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmiasCardiovascular Effects of Exercise

The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Open access

Adabag, A. Selcuk, Casey, Susan A., Kuskowski, Michael A., Zenovich, Andrey G., Maron, Barry J.·2005·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2004.11.043

Open this paper in CoChat — free account Open PDF

Abstract

Objectives The goal of this study was to assemble a profile and assess the significance of arrhythmias in a nontertiary-based hypertrophic cardiomyopathy (HCM) cohort.Background Hypertrophic cardiomyopathy is associated with arrhythmia-related consequences, particularly sudden death. Ventricular tachyarrhythmias on Holter electrocardiograms (ECG) have been reported as markers for sudden death in highly selected HCM populations.Methods We assessed the profile of ventricular and supraventricular ectopy and bradyarrhythmia on ambulatory 24-h Holter ECG and also related these findings to clinical outcome in 178 HCM patients.Results Of the 178 study patients, 157 (88%) had premature ventricular complexes (PVCs), including 21 (12%) with >/=500 PVCs, 74 (42%) had couplets, 67 (37%) had supraventricular tachycardia (SVT), and 56 (31%) had nonsustained ventricular tachycardia (NSVT). Mean number of PVCs was 330 +/- 763 (range 1 to 5,435) and increased with age (p < 0.01); NSVT was associated with greater left ventricular hypertrophy (p = 0.01) and severe symptoms (New York Heart Association functional classes III and IV) (p = 0.04); SVT occurred more commonly in patients with outflow obstruction (p = 0.02). Over a follow-up of 5.5 +/- 3.4 years, 11 (6%) patients died suddenly (annual mortality rate, 1.1%) including 5 patients with NSVT. For sudden death, NSVT on Holter ECG had negative and positive predictive values of 95% and 9%, and sensitivity and specificity of 45% and 69%, respectively.Conclusions In this nontertiary-based HCM cohort, ventricular and supraventricular tachyarrhythmias were particularly frequent and demonstrated a broad spectrum on ambulatory (Holter) ECG. Paradoxically, despite such a highly arrhythmogenic substrate, sudden death events proved to be relatively uncommon. Ventricular tachyarrhythmias had a low positive and relatively high negative predictive value for sudden death in this HCM population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2004.11.043

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,119
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citation
Hypertrophic Cardiomyopathy
Hypertensive, Y., & Chin, K. (1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,757
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citation
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citation
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Self-citation
The Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,050
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026
Self-citation
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citation

Show all 38 references

Sorted by citations

Items 101–200 of 271

Management of hypertrophic cardiomyopathy
Zhang, Y., Adamo, M., Zou, C., Porcari, A., Tomasoni, D., Rossi, M., Merlo, M., Liu, H., Wang, J., Zhou, P., et al. (2024) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001616 · Cited by 21
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Adamczak, D., & Oko‐Sarnowska, Z. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000184 · Cited by 19
Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy
Yan, L., Zhao, S., Wang, H., Duan, F., Wang, Z., Yang, Y., Guo, X., Cai, C., Xu, Z.-M., Li, Y., et al. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000163 · Cited by 18
EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias
Magnusson, P., & Mörner, S. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14792 · Cited by 18
Holter Monitoring and Long-Term Prognosis in Hypertrophic Cardiomyopathy
Kawasaki, T., Sakai, C., Harimoto, K., Yamano, M., Miki, S., Kamitani, T., & Sugihara, H. (2012) · Cardiology · doi:10.1159/000338156 · Cited by 18
Left ventricular remodeling leads to heart failure in mice with cardiac‐specific overexpression of VEGF‐B167: echocardiography and magnetic resonance imaging study
Lottonen‐Raikaslehto, L., Rissanen, R., Gurzeler, E., Merentie, M., Huusko, J., Schneider, J. E., Liimatainen, T., & Ylä‐Herttuala, S. (2017) · Physiological Reports · doi:10.14814/phy2.13096 · Cited by 17
Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model
Toib, A., Zhang, C., Borghetti, G., Zhang, X., Wallner, M., Yang, Y., Troupes, C. D., Kubo, H., Sharp, T. E., Feldsott, E. A., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00167.2017 · Cited by 17
Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy
Raiker, N. K., Vullaganti, S., Collins, J. D., Allen, B. D., & Choudhury, L. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01808-6 · Cited by 17
A Primer on Arrhythmias in Patients with Hypertrophic Cardiomyopathy
Bockstall, K. E., & Link, M. S. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0297-3 · Cited by 17
Significance of Maximal and Regional Left Ventricular Wall Thickness in Association With Arrhythmic Events in Patients With Hypertrophic Cardiomyopathy
Püntmann, V. O., Yap, Y. G., McKenna, W. J., & Camm, A. J. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0723 · Cited by 16
Prognostic Significance of Incidental Nonsustained Ventricular Tachycardia Detected on Pacemaker Interrogation
Jamil, H. A., Mohammed, S., Gierula, J., Paton, M. F., Lowry, J. E., Cubbon, R. M., Kearney, M. T., & Witte, K. K. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.040 · Cited by 15
Heart muscle disease management in aircrew
D’Arcy, J. L., Manen, O., Davenport, E. D., Syburra, T., Rienks, R., Guettler, N. J., Bron, D., Gray, G. W., & Nicol, E. D. (2018) · Heart · doi:10.1136/heartjnl-2018-313058 · Cited by 15
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
Nazarian, S., & Lima, J. A. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.010 · Cited by 15
Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Emet, S., Dadashov, M., Sonsöz, M. R., Çakır, M. O., Yılmaz, M., Elitok, A., Bilge, A. K., Mercanoğlu, F., Öncül, A., Adalet, K., et al. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.013 · Cited by 15
Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy
Magrì, D., Cecco, C. N. D., Piccirillo, G., Mastromarino, V., Serdoz, A., Muscogiuri, G., Ricotta, A., Gregori, M., Marino, L., Cauti, F. M., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1423 · Cited by 14
Risk stratification in hypertrophic cardiomyopathy
Marrakchi, S., Kammoun, I., Bennour, E., Laroussi, L., & Kachboura, S. (2018) · Herz · doi:10.1007/s00059-018-4700-8 · Cited by 14
Deleterious Rare Desmosomal Variants Contribute to Hypertrophic Cardiomyopathy and Are Associated With Distinctive Clinical Features
Wu, G., Liu, J., Ruan, J., Yu, S., Wang, L., Zhao, S., Wang, S., Kang, L., Wang, J., & Song, L. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.08.022 · Cited by 14
Perspectives on Sudden Death Prevention in Hypertrophic Cardiomyopathy
Efthimiadis, G. K., Zegkos, T., Meditskou, S., & Hadjimiltiades, S. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000017 · Cited by 12
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases
Volpato, G., Falanga, U., Cipolletta, L., Conti, M. A., Grifoni, G., Ciliberti, G., Urbinati, A., Barbarossa, A., Stronati, G., Fogante, M., et al. (2021) · Medicina · doi:10.3390/medicina57040308 · Cited by 15
Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy
Jensen, M. K., Havndrup, O., Hassager, C., Helqvist, S., Kelbæk, H., Jørgensen, E. O., Køber, L., & Bundgaard, H. (2011) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2011.565793 · Cited by 12
New Appearance of Fragmented QRS as a Predictor of Ventricular Arrhythmic Events in Patients With Hypertrophic Cardiomyopathy
Ogura, S., Nakamura, K., Morita, H., Toh, N., Nakagawa, K., Yoshida, M., Watanabe, A., Nishii, N., Miyoshi, T., & Ito, H. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-0968 · Cited by 12
2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death
Mikhailov, E. N., Gizatulina, T. P., Lebedev, D. S., Golukhova, E. Z., Kharlap, M. S., Лебедева, В. К., Bagnenko, S. F., Artyukhina, Е. А., Babokin, V. E., Batalov, R. E., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6670 · Cited by 14
Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy
Rowin, E. J., Das, G., Madias, C. A., Hsu, M., Crosson, L. A., Turakhia, M. P., Maron, B. J., & Maron, M. S. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.09.040 · Cited by 12
Self-citation
Mid‐ventricular obstruction is associated with non‐sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy
Nie, C., Zhu, C., Xiao, M., Yang, Q., Meng, Y., Wu, R., & Wang, S. (2021) · Clinical Cardiology · doi:10.1002/clc.23575 · Cited by 11
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11
Ventricular Arrhythmias and Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy
Mattos, B. P. E., Torres, M. A. R., de Freitas, V. C., Scolari, F. L., & de Loreto, M. S. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130078 · Cited by 11
Avaliação diagnóstica da cardiomiopatia hipertrófica em fase clínica e pré-clínica
Mattos, B. P. E., Torres, M. A. R., & de Freitas, V. C. (2008) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2008001300009 · Cited by 11
Prognostic implications of nonsustained ventricular tachycardia morphology in high‐risk patients with hypertrophic cardiomyopathy
Adduci, C., Boldini, F., Palano, F., Musumeci, B., Lucia, C. D., Russo, D., Volpe, M., Autore, C., & Francia, P. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14571 · Cited by 11
Electrocardiographic Predictors of Arrhythmic Death
McLaughlin, M. G., & ZIMETBAUM, P. J. (2006) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2006.00125.x · Cited by 11
Clinical Significance of Nonsustained Ventricular Tachycardia on Routine Monitoring of Pacemaker Patients
Seth, N., Kaplan, R. M., Bustamante, E., Kulkarni, C. V., Subacius, H. P., Rosenthal, J. E., & PASSMAN, R. S. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12632 · Cited by 11
Ambulatory electrocardiogram recordings in cats with primary asymptomatic hypertrophic cardiomyopathy
Hanås, S., Tidholm, A., & Holst, B. S. (2015) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x15618702 · Cited by 11
Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.001 · Cited by 10
Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy
Liu, L., Liu, S., Shen, L., Tu, B., Hu, Z., Hu, F., Zheng, L., Ding, L., Fan, X., & Yao, Y. (2020) · Clinical Cardiology · doi:10.1002/clc.23425 · Cited by 10
The Prevalence and the Prognostic Value of Microvolt T-Wave Alternans in Patients with Hypertrophic Cardiomyopathy
Trzos, E., Kasprzak, J. D., Krzemińska‐Pakuła, M., Rechciński, T., Wierzbowska-Drabik, K. A., Uznańska, B., Śmiałowski, A., Rudziński, T., & Kurpesa, M. (2011) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2011.00443.x · Cited by 10
Terapia con desfibrilador automático implantable en la miocardiopatía hipertrófica: utilidad en prevención primaria y secundaria
Sarrias, A., Galve, E., Sabaté, X., Moya‐Mitjans, À., Anguera, I., Núñez, E., Villuendas, R., Alcalde, Ó., & David Garcia-dorado, A. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.05.024 · Cited by 9
Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters
El-Saiedi, S. A., Behairy, N. H. E. D., Kharabish, A. E., Esmail, R., Seliem, Z. S., Shafik, M., & Mozy, W. E. (2017) · Pediatric Cardiology · doi:10.1007/s00246-017-1612-y · Cited by 9
Sudden cardiac death in patients with nonischemic cardiomyopathy
Betensky, B. P., & Dixit, S. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2013.12.047 · Cited by 9
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
Sánchez, D. J., & Lozano, I. F. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.31 · Cited by 9
Association between exposure to Efavirenz and substrates of dysrhythmia in HIV ‐infected young adults
Hosseini, Z., Mollazadeh, R., Manshadi, S. A. D., Mohebi, M., Eslami, M., Sadre‐Bafghi, S., Akbari, A., & Ghodsi, S. (2021) · Clinical Cardiology · doi:10.1002/clc.23705 · Cited by 8
Hypertrophic cardiomyopathy with apical aneurysm: left ventricular reconstruction and cryoablation for ventricular tachycardia
Osawa, H., Fujimatsu, T., Takai, F., & Suzuki, H. (2011) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-010-0695-7 · Cited by 8
Estratificação de risco para morte súbita na cardiomiopatia hipertrófica: bases genéticas e clínicas
Mattos, B. P. E. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001600024 · Cited by 8
Early repolarization in the inferolateral leads of the electrocardiogram : prevalence, prognosis and characteristics
Tikkanen, J. T. (2013) · Cited by 7
Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy
Walker, A. L., Ueda, Y., Crofton, A. E., Harris, S. P., & Stern, J. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-05999-x · Cited by 7
Hypertrophic cardiomyopathy with apical aneurysm
Sun, J. P., Yang, X. S., Wong, K., & Yu, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.093 · Cited by 7
Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy
Proietti, R., Russo, V., & AlTurki, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.004 · Cited by 7
Ventricular arrhythmias and risk stratification of cardiac sudden death in athletes
Crescenzi, C., Panattoni, G., Stazi, A., Martino, A., Sgueglia, M., Ruvo, E. D., & Calò, L. (2020) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.20.05178-6 · Cited by 8
of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society American Association for Thoracic Surgery, American Society of Foundation/American Heart Association Task Force on Practice Guidelines Cardiomyopathy: A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic
Towbin, J. A., Udelson, J. E., Nishimura, R. A., Ommen, S. R., Rakowski, H., Bonow, R. O., Dearani, J. A., Fifer, M. A., Gersh, B. J., & Maron, B. J. (2011) · Cited by 7
Self-citation
Nonsustained Ventricular Tachycardia
Katritsis, D. G., Zaręba, W., & Camm, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00045-4 · Cited by 7
Significance of Appropriate Defibrillator Shock 3 Hours and 20 Minutes Following Implantation in a Patient with Hypertrophic Cardiomyopathy
Almquist, A. K., Hanna, C. A., Haas, T. S., & Maron, B. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00942.x · Cited by 7
Self-citation
Evaluation of sudden cardiac death in hypertrophic cardiomyopathy
Yoon, S. G., & Hong, G. (2025) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-025-00054-5 · Cited by 7
Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators
Pasqua, T., Tropea, T., Granieri, M. C., Bartolo, A. D., Spena, A. R., Moccia, F. D., Rocca, C., & Angelone, T. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107003 · Cited by 6
Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
Yazaki, K., Suzuki, A., Shiga, T., Minami, Y., Arai, K., Ashihara, K., Shoda, M., & Hagiwara, N. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01910-0 · Cited by 6
Romanian Registry of Hypertrophic Cardiomyopathy – overview of general characteristics and therapeutic choices at a national level
Ionilă, P., Jurcut, R. O., Ferariu, N., Roşca, M., Chivulescu, M., Mursă, A., Militaru, S., Ionescu, A. A., Căldăraru, C., Fruntelata, A. G., et al. (2018) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2018-0012 · Cited by 6
Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art Review
Chia, K. K. M., Kanagaratnam, L. B., Hellestrand, K. J., Kowey, P. R., & Whalley, D. W. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.10.002 · Cited by 6
Impact of Left Ventricular Ejection Fraction on Recurrent Ventricular Tachyarrhythmias in Recipients of Implantable Cardioverter Defibrillators
Rusnak, J., Behnes, M., Weiß, C., Nienaber, C. A., Reiser, L., Schupp, T., Bollow, A., Taton, G., Reichelt, T., Ellguth, D., et al. (2020) · Cardiology · doi:10.1159/000504876 · Cited by 6
Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
Zhang, H., Ding, L., Weng, S.-X., Zhou, B., Ding, X., Hu, L., Qi, Y., Yu, F., Feng, T., Zhang, J.-T., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.766571 · Cited by 6
Hypertrophic Cardiomyopathy
Maron, B. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00069-x · Cited by 6
Self-citation
Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy
Chu, L. C. H., Corona‐Villalobos, C. P., Halushka, M. K., Zhang, Y., Pozzessere, C., Kamel, I. R., Pozios, I., van der Geest, R. J., Gai, N., Abraham, R. M., et al. (2016) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000564 · Cited by 6
Holter monitoring in the prognosis of sudden cardiac death.
Erdoğan, O. (2007) · PubMed · Cited by 6
Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with Mavacamten
Badr, A., Roehl, K. M., Suppah, M., Abdullah, H. A., Arsanjani, R., Siontis, K. C., Geske, J. B., Ommen, S. R., Giudicessi, J. R., & Alsidawi, S. (2025) · Biomedicines · doi:10.3390/biomedicines13041005 · Cited by 5
Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels
Perez, M. V., Wheeler, M. T., Ho, M. Y., Pavlović, A., Wang, P. J., & Ashley, E. A. (2008) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-008-9030-4 · Cited by 5
Exercise Testing for Risk Stratification of Ventricular Arrhythmias in the Athlete
Schmied, C. M., Brunckhorst, C., Duru, F., & Haegeli, L. (2013) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.11.003 · Cited by 5
Surgery of Hypertrophic Obstructive Cardiomyopathy in Patients With Severe Hypertrophy, Myocardial Fibrosis, and Ventricular Tachycardia
Borisov, K. V. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.02.017 · Cited by 5
Atrial Fibrillation in Hypertrophic Cardiomyopathy
Игнатенко, Г. А., Тарадин, Г. Г., Ватутин, Н. Т., Kaluga, A. A., & Kostyamin, Y. D. (2021) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2021-11-3-173-185 · Cited by 5
Arrhythmias Associated with Electroconvulsive Therapy in Hypertrophic Cardiomyopathy
Adabağ, S., Kim, H. G., & Aloul, B. A. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00979.x · Cited by 5
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands*
Christiaans, I., Nannenberg, E. A., Dooijes, D., Jongbloed, R. J. E., Michels, M., Postema, P. G., Majoor‐Krakauer, D. F., van den Wijngaard, A., Mannens, M. M. A. M., van Tintelen, J. P., et al. (2014) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0705-0_6 · Cited by 5
Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy
Tesic, M. B., Travica, L., Giga, V. L., Jovanović, I., Trifunović, D., Popović, D., Mladenovic, D., Radomirović, M., Vratonjic, J., Boskovic, N., et al. (2023) · Medicina · doi:10.3390/medicina59101798 · Cited by 4
Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
Burnasheva, G. A., Myasnikov, R. P., Kulikova, O. V., Kudryavtseva, M. M., Mershina, E. A., & Drapkina, O. M. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3839 · Cited by 4
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
Verheyen, N., Auer, J., Bonaros, N. E., Buchacher, T., Dalos, D., Grimm, M. F., Mayr, A., Rab, A., Reinstadler, S. J., Scherr, D., et al. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02442-1 · Cited by 4
Cardiovascular Diseases and Hypertension
Duiyimuhan, G., Yan, Z.-T., Xu, H., Wang, H., Cai, L., Liu, S., Aibaidula, Z., & Zhou, K. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_12 · Cited by 4
Catheter Ablation for Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Subramanian, M., Atreya, A. R., Yalagudri, S. D., Shekar, P. V., Saggu, D. K., & Narasimhan, C. (2022) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2022.08.005 · Cited by 4
Thirty Controversies and Considerations in Hypertrophic Cardiomyopathy
Masri, A., Nazer, B., Al‐Rashdan, L., Mannello, M., Fischer, K. L., Akhavein, R., Divanji, P., Song, H. K., & Heitner, S. B. (2020) · Structural Heart · doi:10.1080/24748706.2020.1844926 · Cited by 4
Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation
Hayashi, H., Iwasaki, Y., Arai, T., Mimuro, R., Hachisuka, M., Maru, Y., Fujimoto, Y., Oka, E., Hagiwara, K. I., Imori, Y., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01728-4 · Cited by 4
Atrial Flutter in Particular Patient Populations
Compagnucci, P., Casella, M., Bagliani, G., Capestro, A., Volpato, G., Valeri, Y., Cipolletta, L., Parisi, Q., Molini, S., Misiani, A., et al. (2022) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2022.05.002 · Cited by 4
Comparable survival in ischemic and nonischemic cardiomyopathy secondary to ventricular tachyarrhythmias and aborted cardiac arrest
Rusnak, J., Behnes, M., Schupp, T., Weiß, C., Nienaber, C. A., Lang, S., Reiser, L., Bollow, A., Taton, G., Reichelt, T., et al. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000738 · Cited by 4
The Unseen Side of Feline Hypertrophic Cardiomyopathy: Diagnostic and Prognostic Utility of Electrocardiography and Holter Monitoring
Cofaru, A., Murariu, R., Popa, T., Peștean, C. P., & Scurtu, I. C. (2024) · Animals · doi:10.3390/ani14152165 · Cited by 3
Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From the Kochi RYOMA Study ―
Kubo, T., Baba, Y., Ochi, Y., Takahashi, A., Hirota, T., Yamasaki, N., Hamashige, N., Yamamoto, K., Kondo, F., Bando, K., et al. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0056 · Cited by 3
Splenic infarction due to multiple left ventricular mobile thrombi in hypereosinophilic endomyocarditis
Kato, M., Dote, K., & Kaneko, M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm636 · Cited by 3
Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy
Komatsu, J., Imai, R., Nakaoka, Y., Nishida, K., Seki, S.-I., Kubo, T., Yamasaki, N., Kitaoka, H., Kubokawa, S., Kawai, K., et al. (2021) · Circulation Reports · doi:10.1253/circrep.cr-20-0101 · Cited by 3
Hypertrophic Cardiomyopathy
Colan, S. D., & Margossian, R. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00019-3 · Cited by 3
Asystole and scarring of the interventricular septum in hypertrophic cardiomyopathy
Foley, P. W. X., Frenneaux, M. P., & Leyva, F. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283291534 · Cited by 3
Editorial
Kwon, D. H., & Desai, M. Y. (2007) · International journal of cardiac imaging · doi:10.1007/s10554-007-9234-8 · Cited by 3
Outcomes of Transcatheter Edge-to-Edge Mitral Valve Repair in Hypertrophic Cardiomyopathy: A Patient-Level Meta-Analysis
Mascarenhas, L., Yang, G., Sharma, A. N., Bertog, S. C., Hubers, S. A., & Adabağ, S. (2025) · Structural Heart · doi:10.1016/j.shj.2025.100664 · Cited by 2
Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy
Jin, S., Li, M., Jiang, C., Tang, R., Sang, C., Wang, W., Zhao, X., Li, C., Li, S., Guo, X., et al. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.05.028 · Cited by 2
Nationwide Trends in Demographics, Comorbidities, and Mortality Among Elderly Patients with Heart Failure with Preserved Ejection Fraction Hospitalized with Cardiac Arrest
Mohammed, A. S., Takagi, M. A., Yasmeen, U., Gandhi, A., KHAN, A. F., Popat, A., Desai, R., Kambali, S., Koshak, A. K. A., & Mandoorah, S. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110559 · Cited by 2
Sudden Cardiac Death in Coronary Artery Disease
Safavi‐Naeini, P., Rasekh, A., Razavi, M., Saeed, M., & Massumi, A. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_24 · Cited by 2
Advancements in the diagnosis and management of premature ventricular contractions in pediatric patients
Zhu, W., Yuan, H., & Lv, J. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1373772 · Cited by 2
The global morphological analysis of a time-delay embedding of the scalar time series
Ćosić, M., & Miljković, N. (2024) · Nonlinear Dynamics · doi:10.1007/s11071-024-09750-1 · Cited by 2
Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
Sarrias, A., Galve, E., Sabaté, X., Moya‐Mitjans, À., Anguera, I., Núñez, E., Villuendas, R., Alcalde, Ó., & David Garcia-dorado, A. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.06.025 · Cited by 2
Hypertrophic cardiomyopathy--state of the art in 2007.
Monteiro, S. R., Costa, S., Monteiro, P., Gonçalves, L. M. M., & Providência, L. A. (2008) · PubMed · Cited by 2
Ventricular arrhythmias and sudden death in hypertrophic cardiomyopathy
Durdil, V. (2010) · Cor et Vasa · doi:10.33678/cor.2010.118 · Cited by 2
Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
Reza, N., de Feria, A., Wang, T., Chowns, J. L., Hoffman‐Andrews, L., Kim, J., Hornsby, N., Marzolf, A. B., Atluri, P., Herrmann, H. C., et al. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001279 · Cited by 2
Hypertrophic Cardiomyopathy
Christiaans, I., & Elliot, P. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_4 · Cited by 2
Ventricular tachycardia risk prediction with an abbreviated duration mobile cardiac telemetry
Lundeberg, J. E., Måneheim, A., Persson, A., Dziubinski, M. J., Sridhar, A. R. M., Healey, J. S., Slusarczyk, M., Engström, G., & Johnson, L. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.06.009 · Cited by 2
Ventricular arrhythmias complicating hypertrophic cardiomyopathy
Hutchings, D. C., Sankaranarayanan, R., & Venetucci, L. A. (2012) · British Journal of Hospital Medicine · doi:10.12968/hmed.2012.73.9.502 · Cited by 2
EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)—rationale and design: a prospective observational study on incidence of arrhythmias in Sweden
Magnusson, P., & Mörner, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-019541 · Cited by 2
Defibrillator Therapies in Hypertrophic Cardiomyopathy: Too Many Swings at Bad Pitches?
Kim, S. S., & Knight, B. P. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00786.x · Cited by 2
Current status of implantable cardioverter-defibrillator therapy in heart failure
Can, İ., & Tholakanahalli, V. N. (2009) · Current Heart Failure Reports · doi:10.1007/s11897-009-0028-2 · Cited by 1
Management of Arrhythmias in Heart Failure
Podrid, P. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10053-1 · Cited by 1
[Characteristics of the inferior wall hypertrophy in hypertrophic cardiomyopathy patients with contrast echocardiography].
Liu, Z., Zhang, W., Jing, X., Lei, X., & Huang, H. (2018) · PubMed Central · doi:10.7507/1001-5515.201707053 · Cited by 1

Authors: Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J.
Affiliations: Minneapolis Heart Institute Foundation (US)
Minneapolis VA Medical Center (US)
ORCID: Casey, Susan A.
Maron, Barry J.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2005-03
Volume: 45
Issue: 5
Pages: 697-704
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2004.11.043
OpenAlex: W2134380184
Cited by: 273
References: 38
Citations by year: 2026: 5 · 2025: 14 · 2024: 12 · 2023: 6 · 2022: 6 · 2021: 20 · 2020: 26 · 2019: 8 · 2018: 24 · 2017: 19 · 2016: 11 · 2015: 15 · 2014: 20 · 2013: 11 · 2012: 12
FWCI: 6.38
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 3096 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: hypertrophic cardiomyopathy, ventricular arrhythmias, premature ventricular contractions, non-sustained ventricular tachycardia, supraventricular tachycardia, sudden death, prognostic factors, Holter monitoring, left ventricular hypertrophy, outflow obstruction, bradycardia
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Bradycardia, Cardiomyopathy, Hypertrophic, Child, Child, Preschool, Female, Follow-Up Studies, Hospitals, Community, Humans, Male, Middle Aged, Minnesota, Risk Factors, Tachycardia, Supraventricular, Electrocardiography, Ambulatory, Comorbidity, Survival Analysis, Cardiology Service, Hospital, Death, Sudden, Cardiac, Tachycardia, Ventricular, Ventricular Premature Complexes, Atrial Premature Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks